Research progress and perspectives of dual-target inhibitors

Area of Science:

• Pharmacology and Medicinal Chemistry
• Drug Discovery and Development
• Disease Pathophysiology

Background:

• Complex diseases often involve multiple targets, limiting the efficacy of single-target drugs.
• Dual-target inhibition presents a strategy to enhance therapeutic effects and patient tolerance.
• Dual-target inhibitors are a rapidly advancing area in drug development.

Purpose of the Study:

• To review the design strategies and research progress of dual-target inhibitors.
• To highlight the application of dual-target inhibitors in various disease areas.
• To underscore the importance of targeting multiple pathways for improved therapeutic outcomes.

Main Methods:

• Literature review of dual-target inhibitor research.
• Summarization of design principles for dual-target drugs.
• Analysis of current research progress across different disease categories.

Main Results:

• Dual-target inhibitors can offer synergistic effects, leading to improved efficacy.
• This approach has shown potential in neurodegenerative, infectious, metabolic, and cardiovascular diseases.
• Successful dual-target drug design requires careful consideration of target interaction and drug properties.

Conclusions:

• Dual-target inhibitors represent a significant advancement in treating complex diseases.
• Further research into design strategies and clinical applications is warranted.
• This approach holds promise for developing more effective and tolerable therapeutics.